Tag Archives: infliximab

June, 2018

April, 2017

January, 2017

  • 18 January

    Facing Down Crohn’s and Related Diseases

    Inflammatory bowel disease – which includes both Crohn’s disease and ulcerative colitis – affects 1.6 million Americans, a number that continues to rise. Each year, the U.S. sees 70,000 new cases diagnosed. Although a cure remains elusive, these chronic and life-long diseases can be treated with a variety of treatment …

September, 2016

  • 19 September

    Pfizer’s Remicade Biosimilar Candidate Succeeds in Late-Stage Study

    NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) announced the confirmatory study (REFLECTIONS B537-02) evaluating the efficacy, safety, and immunogenicity of PF-06438179 (infliximab-Pfizer) compared to Remicade® (infliximab) met its primary endpoint. The trial demonstrated equivalent efficacy of the proposed biosimilar PF-06438179 to the originator product as measured by the American College of Rheumatology …

April, 2016

March, 2016

February, 2016